Nyrada (ASX:NYR) Inc's James Bonnar speaks with Proactive at the ASX Small and Mid Cap Conference. Nyrada is a preclinical stage, drug discovery, and development company, specialising in novel small molecule drugs to treat cardiovascular and neurological diseases. It has two main programs - a cholesterol-lowering drug and a drug to treat brain injury.
Nyrada Inc with Proactive at the ASX Small and Mid Cap Conference
